nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—ankylosing spondylitis	0.392	1	CiPCiCtD
Pemetrexed—Methotrexate—ankylosing spondylitis	0.256	1	CrCtD
Pemetrexed—SLC46A1—Sulfasalazine—ankylosing spondylitis	0.0728	0.427	CbGbCtD
Pemetrexed—ATIC—Methotrexate—ankylosing spondylitis	0.0367	0.216	CbGbCtD
Pemetrexed—Folic Acid—Methotrexate—ankylosing spondylitis	0.0339	0.2	CrCrCtD
Pemetrexed—Leucovorin—Methotrexate—ankylosing spondylitis	0.0339	0.2	CrCrCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—ankylosing spondylitis	0.0339	0.2	CrCrCtD
Pemetrexed—Raltitrexed—Methotrexate—ankylosing spondylitis	0.0339	0.2	CrCrCtD
Pemetrexed—Pralatrexate—Methotrexate—ankylosing spondylitis	0.0339	0.2	CrCrCtD
Pemetrexed—SLC46A1—Methotrexate—ankylosing spondylitis	0.0292	0.171	CbGbCtD
Pemetrexed—DHFR—Methotrexate—ankylosing spondylitis	0.0186	0.11	CbGbCtD
Pemetrexed—TYMS—Methotrexate—ankylosing spondylitis	0.013	0.0763	CbGbCtD
Pemetrexed—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	4.84e-05	0.00406	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	4.84e-05	0.00406	CcSEcCtD
Pemetrexed—Conjunctivitis—Triamcinolone—ankylosing spondylitis	4.81e-05	0.00403	CcSEcCtD
Pemetrexed—Mood swings—Prednisone—ankylosing spondylitis	4.81e-05	0.00403	CcSEcCtD
Pemetrexed—Renal failure acute—Methotrexate—ankylosing spondylitis	4.59e-05	0.00385	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	4.48e-05	0.00375	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	4.43e-05	0.00371	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	4.43e-05	0.00371	CcSEcCtD
Pemetrexed—Pharyngitis—Triamcinolone—ankylosing spondylitis	4.41e-05	0.00369	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	4.4e-05	0.00369	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	4.4e-05	0.00369	CcSEcCtD
Pemetrexed—Myocardial infarction—Dexamethasone—ankylosing spondylitis	4.4e-05	0.00369	CcSEcCtD
Pemetrexed—Myocardial infarction—Betamethasone—ankylosing spondylitis	4.4e-05	0.00369	CcSEcCtD
Pemetrexed—Conjunctivitis—Betamethasone—ankylosing spondylitis	4.37e-05	0.00366	CcSEcCtD
Pemetrexed—Conjunctivitis—Dexamethasone—ankylosing spondylitis	4.37e-05	0.00366	CcSEcCtD
Pemetrexed—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	4.33e-05	0.00363	CcSEcCtD
Pemetrexed—Arrhythmia—Prednisolone—ankylosing spondylitis	4.32e-05	0.00362	CcSEcCtD
Pemetrexed—Pancreatitis—Prednisone—ankylosing spondylitis	4.3e-05	0.0036	CcSEcCtD
Pemetrexed—Erythema—Prednisolone—ankylosing spondylitis	4.21e-05	0.00352	CcSEcCtD
Pemetrexed—Eye disorder—Methylprednisolone—ankylosing spondylitis	4.14e-05	0.00347	CcSEcCtD
Pemetrexed—Neutropenia—Prednisone—ankylosing spondylitis	4.1e-05	0.00344	CcSEcCtD
Pemetrexed—Mood swings—Methotrexate—ankylosing spondylitis	4.02e-05	0.00337	CcSEcCtD
Pemetrexed—Arrhythmia—Triamcinolone—ankylosing spondylitis	3.97e-05	0.00333	CcSEcCtD
Pemetrexed—Arrhythmia—Methylprednisolone—ankylosing spondylitis	3.96e-05	0.00332	CcSEcCtD
Pemetrexed—Erythema—Triamcinolone—ankylosing spondylitis	3.87e-05	0.00324	CcSEcCtD
Pemetrexed—Erythema—Methylprednisolone—ankylosing spondylitis	3.86e-05	0.00323	CcSEcCtD
Pemetrexed—Malnutrition—Methylprednisolone—ankylosing spondylitis	3.86e-05	0.00323	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Prednisone—ankylosing spondylitis	3.86e-05	0.00323	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Prednisone—ankylosing spondylitis	3.83e-05	0.00321	CcSEcCtD
Pemetrexed—Myocardial infarction—Prednisone—ankylosing spondylitis	3.83e-05	0.00321	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	3.82e-05	0.0032	CcSEcCtD
Pemetrexed—Dysgeusia—Triamcinolone—ankylosing spondylitis	3.79e-05	0.00317	CcSEcCtD
Pemetrexed—Syncope—Prednisolone—ankylosing spondylitis	3.77e-05	0.00316	CcSEcCtD
Pemetrexed—Eye disorder—Dexamethasone—ankylosing spondylitis	3.77e-05	0.00316	CcSEcCtD
Pemetrexed—Eye disorder—Betamethasone—ankylosing spondylitis	3.77e-05	0.00316	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisolone—ankylosing spondylitis	3.7e-05	0.0031	CcSEcCtD
Pemetrexed—Hypertension—Prednisolone—ankylosing spondylitis	3.63e-05	0.00304	CcSEcCtD
Pemetrexed—Arrhythmia—Dexamethasone—ankylosing spondylitis	3.6e-05	0.00302	CcSEcCtD
Pemetrexed—Arrhythmia—Betamethasone—ankylosing spondylitis	3.6e-05	0.00302	CcSEcCtD
Pemetrexed—Pancreatitis—Methotrexate—ankylosing spondylitis	3.59e-05	0.00301	CcSEcCtD
Pemetrexed—Alopecia—Betamethasone—ankylosing spondylitis	3.56e-05	0.00298	CcSEcCtD
Pemetrexed—Alopecia—Dexamethasone—ankylosing spondylitis	3.56e-05	0.00298	CcSEcCtD
Pemetrexed—Erythema—Betamethasone—ankylosing spondylitis	3.51e-05	0.00294	CcSEcCtD
Pemetrexed—Erythema—Dexamethasone—ankylosing spondylitis	3.51e-05	0.00294	CcSEcCtD
Pemetrexed—Pancytopenia—Methotrexate—ankylosing spondylitis	3.48e-05	0.00292	CcSEcCtD
Pemetrexed—Syncope—Triamcinolone—ankylosing spondylitis	3.47e-05	0.00291	CcSEcCtD
Pemetrexed—Syncope—Methylprednisolone—ankylosing spondylitis	3.46e-05	0.0029	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisolone—ankylosing spondylitis	3.43e-05	0.00288	CcSEcCtD
Pemetrexed—Oedema—Prednisolone—ankylosing spondylitis	3.43e-05	0.00288	CcSEcCtD
Pemetrexed—Neutropenia—Methotrexate—ankylosing spondylitis	3.43e-05	0.00287	CcSEcCtD
Pemetrexed—Loss of consciousness—Triamcinolone—ankylosing spondylitis	3.4e-05	0.00285	CcSEcCtD
Pemetrexed—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	3.39e-05	0.00284	CcSEcCtD
Pemetrexed—Shock—Prednisolone—ankylosing spondylitis	3.38e-05	0.00283	CcSEcCtD
Pemetrexed—Hypertension—Triamcinolone—ankylosing spondylitis	3.34e-05	0.0028	CcSEcCtD
Pemetrexed—Hypertension—Methylprednisolone—ankylosing spondylitis	3.33e-05	0.00279	CcSEcCtD
Pemetrexed—Myalgia—Triamcinolone—ankylosing spondylitis	3.29e-05	0.00276	CcSEcCtD
Pemetrexed—Arthralgia—Methylprednisolone—ankylosing spondylitis	3.29e-05	0.00275	CcSEcCtD
Pemetrexed—Myalgia—Methylprednisolone—ankylosing spondylitis	3.29e-05	0.00275	CcSEcCtD
Pemetrexed—Eye disorder—Prednisone—ankylosing spondylitis	3.28e-05	0.00275	CcSEcCtD
Pemetrexed—Infestation NOS—Methotrexate—ankylosing spondylitis	3.27e-05	0.00274	CcSEcCtD
Pemetrexed—Infestation—Methotrexate—ankylosing spondylitis	3.27e-05	0.00274	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	3.26e-05	0.00273	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	3.24e-05	0.00271	CcSEcCtD
Pemetrexed—Renal failure—Methotrexate—ankylosing spondylitis	3.21e-05	0.00269	CcSEcCtD
Pemetrexed—Stomatitis—Methotrexate—ankylosing spondylitis	3.19e-05	0.00267	CcSEcCtD
Pemetrexed—Conjunctivitis—Methotrexate—ankylosing spondylitis	3.18e-05	0.00266	CcSEcCtD
Pemetrexed—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	3.16e-05	0.00264	CcSEcCtD
Pemetrexed—Oedema—Triamcinolone—ankylosing spondylitis	3.16e-05	0.00264	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	3.15e-05	0.00264	CcSEcCtD
Pemetrexed—Syncope—Betamethasone—ankylosing spondylitis	3.15e-05	0.00264	CcSEcCtD
Pemetrexed—Syncope—Dexamethasone—ankylosing spondylitis	3.15e-05	0.00264	CcSEcCtD
Pemetrexed—Arrhythmia—Prednisone—ankylosing spondylitis	3.14e-05	0.00263	CcSEcCtD
Pemetrexed—Infection—Triamcinolone—ankylosing spondylitis	3.14e-05	0.00263	CcSEcCtD
Pemetrexed—Infection—Methylprednisolone—ankylosing spondylitis	3.13e-05	0.00262	CcSEcCtD
Pemetrexed—Shock—Triamcinolone—ankylosing spondylitis	3.11e-05	0.0026	CcSEcCtD
Pemetrexed—Alopecia—Prednisone—ankylosing spondylitis	3.1e-05	0.0026	CcSEcCtD
Pemetrexed—Shock—Methylprednisolone—ankylosing spondylitis	3.1e-05	0.0026	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	3.09e-05	0.00259	CcSEcCtD
Pemetrexed—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	3.09e-05	0.00259	CcSEcCtD
Pemetrexed—Loss of consciousness—Dexamethasone—ankylosing spondylitis	3.09e-05	0.00258	CcSEcCtD
Pemetrexed—Loss of consciousness—Betamethasone—ankylosing spondylitis	3.09e-05	0.00258	CcSEcCtD
Pemetrexed—Skin disorder—Methylprednisolone—ankylosing spondylitis	3.06e-05	0.00256	CcSEcCtD
Pemetrexed—Erythema—Prednisone—ankylosing spondylitis	3.06e-05	0.00256	CcSEcCtD
Pemetrexed—Malnutrition—Prednisone—ankylosing spondylitis	3.06e-05	0.00256	CcSEcCtD
Pemetrexed—Agranulocytosis—Methotrexate—ankylosing spondylitis	3.05e-05	0.00256	CcSEcCtD
Pemetrexed—Hypertension—Betamethasone—ankylosing spondylitis	3.03e-05	0.00254	CcSEcCtD
Pemetrexed—Hypertension—Dexamethasone—ankylosing spondylitis	3.03e-05	0.00254	CcSEcCtD
Pemetrexed—Myalgia—Dexamethasone—ankylosing spondylitis	2.99e-05	0.0025	CcSEcCtD
Pemetrexed—Myalgia—Betamethasone—ankylosing spondylitis	2.99e-05	0.0025	CcSEcCtD
Pemetrexed—Pain—Prednisolone—ankylosing spondylitis	2.94e-05	0.00246	CcSEcCtD
Pemetrexed—Hepatitis—Methotrexate—ankylosing spondylitis	2.93e-05	0.00246	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—ankylosing spondylitis	2.91e-05	0.00244	CcSEcCtD
Pemetrexed—Urinary tract disorder—Methotrexate—ankylosing spondylitis	2.9e-05	0.00243	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—ankylosing spondylitis	2.88e-05	0.00241	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	2.88e-05	0.00241	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	2.87e-05	0.0024	CcSEcCtD
Pemetrexed—Oedema—Dexamethasone—ankylosing spondylitis	2.86e-05	0.0024	CcSEcCtD
Pemetrexed—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	2.86e-05	0.0024	CcSEcCtD
Pemetrexed—Anaphylactic shock—Betamethasone—ankylosing spondylitis	2.86e-05	0.0024	CcSEcCtD
Pemetrexed—Oedema—Betamethasone—ankylosing spondylitis	2.86e-05	0.0024	CcSEcCtD
Pemetrexed—Infection—Betamethasone—ankylosing spondylitis	2.85e-05	0.00238	CcSEcCtD
Pemetrexed—Infection—Dexamethasone—ankylosing spondylitis	2.85e-05	0.00238	CcSEcCtD
Pemetrexed—Anaemia—Prednisone—ankylosing spondylitis	2.83e-05	0.00237	CcSEcCtD
Pemetrexed—Shock—Dexamethasone—ankylosing spondylitis	2.82e-05	0.00236	CcSEcCtD
Pemetrexed—Shock—Betamethasone—ankylosing spondylitis	2.82e-05	0.00236	CcSEcCtD
Pemetrexed—Dyspnoea—Triamcinolone—ankylosing spondylitis	2.81e-05	0.00236	CcSEcCtD
Pemetrexed—Nervous system disorder—Betamethasone—ankylosing spondylitis	2.81e-05	0.00235	CcSEcCtD
Pemetrexed—Nervous system disorder—Dexamethasone—ankylosing spondylitis	2.81e-05	0.00235	CcSEcCtD
Pemetrexed—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	2.8e-05	0.00235	CcSEcCtD
Pemetrexed—Thrombocytopenia—Betamethasone—ankylosing spondylitis	2.8e-05	0.00235	CcSEcCtD
Pemetrexed—Dyspepsia—Triamcinolone—ankylosing spondylitis	2.78e-05	0.00233	CcSEcCtD
Pemetrexed—Erythema multiforme—Methotrexate—ankylosing spondylitis	2.77e-05	0.00232	CcSEcCtD
Pemetrexed—Dyspepsia—Methylprednisolone—ankylosing spondylitis	2.77e-05	0.00232	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—ankylosing spondylitis	2.74e-05	0.0023	CcSEcCtD
Pemetrexed—Syncope—Prednisone—ankylosing spondylitis	2.74e-05	0.0023	CcSEcCtD
Pemetrexed—Anorexia—Betamethasone—ankylosing spondylitis	2.73e-05	0.00229	CcSEcCtD
Pemetrexed—Anorexia—Dexamethasone—ankylosing spondylitis	2.73e-05	0.00229	CcSEcCtD
Pemetrexed—Urticaria—Prednisolone—ankylosing spondylitis	2.73e-05	0.00228	CcSEcCtD
Pemetrexed—Fatigue—Triamcinolone—ankylosing spondylitis	2.72e-05	0.00228	CcSEcCtD
Pemetrexed—Fatigue—Methylprednisolone—ankylosing spondylitis	2.72e-05	0.00227	CcSEcCtD
Pemetrexed—Pain—Triamcinolone—ankylosing spondylitis	2.7e-05	0.00226	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisone—ankylosing spondylitis	2.69e-05	0.00225	CcSEcCtD
Pemetrexed—Hypertension—Prednisone—ankylosing spondylitis	2.64e-05	0.00221	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	2.62e-05	0.0279	CbGdCrCtD
Pemetrexed—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	2.61e-05	0.00219	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	2.61e-05	0.00219	CcSEcCtD
Pemetrexed—Arthralgia—Prednisone—ankylosing spondylitis	2.6e-05	0.00218	CcSEcCtD
Pemetrexed—Myalgia—Prednisone—ankylosing spondylitis	2.6e-05	0.00218	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—ankylosing spondylitis	2.59e-05	0.00217	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	2.58e-05	0.00216	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	2.58e-05	0.00216	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	2.57e-05	0.0275	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	2.57e-05	0.0275	CbGdCrCtD
Pemetrexed—Erythema—Methotrexate—ankylosing spondylitis	2.55e-05	0.00214	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—ankylosing spondylitis	2.55e-05	0.00214	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	2.54e-05	0.0271	CbGdCrCtD
Pemetrexed—Hypersensitivity—Prednisolone—ankylosing spondylitis	2.53e-05	0.00212	CcSEcCtD
Pemetrexed—Dyspepsia—Betamethasone—ankylosing spondylitis	2.52e-05	0.00211	CcSEcCtD
Pemetrexed—Dyspepsia—Dexamethasone—ankylosing spondylitis	2.52e-05	0.00211	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	2.52e-05	0.0269	CbGdCrCtD
Pemetrexed—Urticaria—Triamcinolone—ankylosing spondylitis	2.51e-05	0.0021	CcSEcCtD
Pemetrexed—Urticaria—Methylprednisolone—ankylosing spondylitis	2.5e-05	0.0021	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—ankylosing spondylitis	2.5e-05	0.0021	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	2.5e-05	0.0267	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	2.5e-05	0.0267	CbGdCrCtD
Pemetrexed—Body temperature increased—Triamcinolone—ankylosing spondylitis	2.5e-05	0.00209	CcSEcCtD
Pemetrexed—Oedema—Prednisone—ankylosing spondylitis	2.49e-05	0.00209	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisone—ankylosing spondylitis	2.49e-05	0.00209	CcSEcCtD
Pemetrexed—Abdominal pain—Methylprednisolone—ankylosing spondylitis	2.49e-05	0.00209	CcSEcCtD
Pemetrexed—Decreased appetite—Dexamethasone—ankylosing spondylitis	2.49e-05	0.00209	CcSEcCtD
Pemetrexed—Decreased appetite—Betamethasone—ankylosing spondylitis	2.49e-05	0.00209	CcSEcCtD
Pemetrexed—Infection—Prednisone—ankylosing spondylitis	2.48e-05	0.00208	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	2.47e-05	0.00207	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	2.47e-05	0.00207	CcSEcCtD
Pemetrexed—Fatigue—Dexamethasone—ankylosing spondylitis	2.47e-05	0.00207	CcSEcCtD
Pemetrexed—Fatigue—Betamethasone—ankylosing spondylitis	2.47e-05	0.00207	CcSEcCtD
Pemetrexed—Shock—Prednisone—ankylosing spondylitis	2.45e-05	0.00206	CcSEcCtD
Pemetrexed—Pain—Dexamethasone—ankylosing spondylitis	2.45e-05	0.00205	CcSEcCtD
Pemetrexed—Pain—Betamethasone—ankylosing spondylitis	2.45e-05	0.00205	CcSEcCtD
Pemetrexed—Nervous system disorder—Prednisone—ankylosing spondylitis	2.45e-05	0.00205	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	2.44e-05	0.0261	CbGdCrCtD
Pemetrexed—Skin disorder—Prednisone—ankylosing spondylitis	2.42e-05	0.00203	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	2.39e-05	0.0255	CbGdCrCtD
Pemetrexed—Anorexia—Prednisone—ankylosing spondylitis	2.38e-05	0.00199	CcSEcCtD
Pemetrexed—Anaemia—Methotrexate—ankylosing spondylitis	2.36e-05	0.00198	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	2.34e-05	0.00196	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	2.34e-05	0.00196	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	2.33e-05	0.0249	CbGdCrCtD
Pemetrexed—Hypersensitivity—Triamcinolone—ankylosing spondylitis	2.33e-05	0.00195	CcSEcCtD
Pemetrexed—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	2.32e-05	0.00194	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Prednisone—ankylosing spondylitis	2.32e-05	0.0248	CbGdCrCtD
Pemetrexed—Leukopenia—Methotrexate—ankylosing spondylitis	2.29e-05	0.00192	CcSEcCtD
Pemetrexed—Urticaria—Betamethasone—ankylosing spondylitis	2.28e-05	0.00191	CcSEcCtD
Pemetrexed—Urticaria—Dexamethasone—ankylosing spondylitis	2.28e-05	0.00191	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	2.27e-05	0.0019	CcSEcCtD
Pemetrexed—Dizziness—Prednisolone—ankylosing spondylitis	2.27e-05	0.0019	CcSEcCtD
Pemetrexed—Asthenia—Triamcinolone—ankylosing spondylitis	2.27e-05	0.0019	CcSEcCtD
Pemetrexed—Abdominal pain—Dexamethasone—ankylosing spondylitis	2.26e-05	0.0019	CcSEcCtD
Pemetrexed—Abdominal pain—Betamethasone—ankylosing spondylitis	2.26e-05	0.0019	CcSEcCtD
Pemetrexed—Body temperature increased—Betamethasone—ankylosing spondylitis	2.26e-05	0.0019	CcSEcCtD
Pemetrexed—Body temperature increased—Dexamethasone—ankylosing spondylitis	2.26e-05	0.0019	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	2.26e-05	0.0242	CbGdCrCtD
Pemetrexed—Asthenia—Methylprednisolone—ankylosing spondylitis	2.26e-05	0.00189	CcSEcCtD
Pemetrexed—Pruritus—Triamcinolone—ankylosing spondylitis	2.23e-05	0.00187	CcSEcCtD
Pemetrexed—Pruritus—Methylprednisolone—ankylosing spondylitis	2.23e-05	0.00187	CcSEcCtD
Pemetrexed—Dyspepsia—Prednisone—ankylosing spondylitis	2.2e-05	0.00184	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—ankylosing spondylitis	2.17e-05	0.00182	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—ankylosing spondylitis	2.17e-05	0.00182	CcSEcCtD
Pemetrexed—Arthralgia—Methotrexate—ankylosing spondylitis	2.17e-05	0.00182	CcSEcCtD
Pemetrexed—Decreased appetite—Prednisone—ankylosing spondylitis	2.17e-05	0.00182	CcSEcCtD
Pemetrexed—Rash—Prednisolone—ankylosing spondylitis	2.16e-05	0.00181	CcSEcCtD
Pemetrexed—Dermatitis—Prednisolone—ankylosing spondylitis	2.16e-05	0.00181	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	2.16e-05	0.00181	CcSEcCtD
Pemetrexed—Diarrhoea—Methylprednisolone—ankylosing spondylitis	2.16e-05	0.00181	CcSEcCtD
Pemetrexed—Fatigue—Prednisone—ankylosing spondylitis	2.15e-05	0.0018	CcSEcCtD
Pemetrexed—Constipation—Prednisone—ankylosing spondylitis	2.13e-05	0.00179	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	2.12e-05	0.0227	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Methylprednisolone—ankylosing spondylitis	2.09e-05	0.0224	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	2.09e-05	0.0223	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Betamethasone—ankylosing spondylitis	2.09e-05	0.0223	CbGdCrCtD
Pemetrexed—Dizziness—Triamcinolone—ankylosing spondylitis	2.09e-05	0.00175	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—ankylosing spondylitis	2.08e-05	0.00175	CcSEcCtD
Pemetrexed—Dizziness—Methylprednisolone—ankylosing spondylitis	2.08e-05	0.00174	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Methylprednisolone—ankylosing spondylitis	2.07e-05	0.0222	CbGdCrCtD
Pemetrexed—Infection—Methotrexate—ankylosing spondylitis	2.07e-05	0.00174	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Dexamethasone—ankylosing spondylitis	2.06e-05	0.022	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Betamethasone—ankylosing spondylitis	2.06e-05	0.022	CbGdCrCtD
Pemetrexed—Asthenia—Betamethasone—ankylosing spondylitis	2.06e-05	0.00172	CcSEcCtD
Pemetrexed—Asthenia—Dexamethasone—ankylosing spondylitis	2.06e-05	0.00172	CcSEcCtD
Pemetrexed—Nervous system disorder—Methotrexate—ankylosing spondylitis	2.04e-05	0.00171	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—ankylosing spondylitis	2.04e-05	0.00171	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	2.04e-05	0.0218	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Betamethasone—ankylosing spondylitis	2.04e-05	0.0218	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Dexamethasone—ankylosing spondylitis	2.04e-05	0.0218	CbGdCrCtD
Pemetrexed—Gastrointestinal pain—Prednisone—ankylosing spondylitis	2.04e-05	0.00171	CcSEcCtD
Pemetrexed—Nausea—Prednisolone—ankylosing spondylitis	2.04e-05	0.00171	CcSEcCtD
Pemetrexed—Pruritus—Dexamethasone—ankylosing spondylitis	2.03e-05	0.0017	CcSEcCtD
Pemetrexed—Pruritus—Betamethasone—ankylosing spondylitis	2.03e-05	0.0017	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—ankylosing spondylitis	2.03e-05	0.0017	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	2.02e-05	0.0216	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Triamcinolone—ankylosing spondylitis	2.01e-05	0.0215	CbGdCrCtD
Pemetrexed—Vomiting—Triamcinolone—ankylosing spondylitis	2.01e-05	0.00168	CcSEcCtD
Pemetrexed—Vomiting—Methylprednisolone—ankylosing spondylitis	2e-05	0.00168	CcSEcCtD
Pemetrexed—Rash—Triamcinolone—ankylosing spondylitis	1.99e-05	0.00167	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	1.99e-05	0.0213	CbGdCrCtD
Pemetrexed—TYMS—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	1.99e-05	0.0213	CbGdCrCtD
Pemetrexed—Dermatitis—Triamcinolone—ankylosing spondylitis	1.99e-05	0.00167	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—ankylosing spondylitis	1.99e-05	0.00166	CcSEcCtD
Pemetrexed—Rash—Methylprednisolone—ankylosing spondylitis	1.99e-05	0.00166	CcSEcCtD
Pemetrexed—Dermatitis—Methylprednisolone—ankylosing spondylitis	1.98e-05	0.00166	CcSEcCtD
Pemetrexed—Urticaria—Prednisone—ankylosing spondylitis	1.98e-05	0.00166	CcSEcCtD
Pemetrexed—Body temperature increased—Prednisone—ankylosing spondylitis	1.97e-05	0.00165	CcSEcCtD
Pemetrexed—Abdominal pain—Prednisone—ankylosing spondylitis	1.97e-05	0.00165	CcSEcCtD
Pemetrexed—Diarrhoea—Dexamethasone—ankylosing spondylitis	1.96e-05	0.00164	CcSEcCtD
Pemetrexed—Diarrhoea—Betamethasone—ankylosing spondylitis	1.96e-05	0.00164	CcSEcCtD
Pemetrexed—TYMS—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	1.94e-05	0.0208	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisone—ankylosing spondylitis	1.94e-05	0.0207	CbGdCrCtD
Pemetrexed—TYMS—Flunisolide—Prednisone—ankylosing spondylitis	1.91e-05	0.0204	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Methylprednisolone—ankylosing spondylitis	1.91e-05	0.0204	CbGdCrCtD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	1.9e-05	0.00159	CcSEcCtD
Pemetrexed—Dizziness—Betamethasone—ankylosing spondylitis	1.89e-05	0.00159	CcSEcCtD
Pemetrexed—Dizziness—Dexamethasone—ankylosing spondylitis	1.89e-05	0.00159	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Prednisone—ankylosing spondylitis	1.89e-05	0.0202	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisolone—ankylosing spondylitis	1.89e-05	0.0202	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Betamethasone—ankylosing spondylitis	1.88e-05	0.0201	CbGdCrCtD
Pemetrexed—TYMS—Diflorasone—Dexamethasone—ankylosing spondylitis	1.88e-05	0.0201	CbGdCrCtD
Pemetrexed—Nausea—Triamcinolone—ankylosing spondylitis	1.88e-05	0.00157	CcSEcCtD
Pemetrexed—Nausea—Methylprednisolone—ankylosing spondylitis	1.87e-05	0.00157	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Prednisolone—ankylosing spondylitis	1.87e-05	0.0199	CbGdCrCtD
Pemetrexed—Dyspnoea—Methotrexate—ankylosing spondylitis	1.86e-05	0.00156	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Prednisolone—ankylosing spondylitis	1.85e-05	0.0197	CbGdCrCtD
Pemetrexed—Hypersensitivity—Prednisone—ankylosing spondylitis	1.84e-05	0.00154	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Triamcinolone—ankylosing spondylitis	1.84e-05	0.0196	CbGdCrCtD
Pemetrexed—Dyspepsia—Methotrexate—ankylosing spondylitis	1.84e-05	0.00154	CcSEcCtD
Pemetrexed—Vomiting—Betamethasone—ankylosing spondylitis	1.82e-05	0.00153	CcSEcCtD
Pemetrexed—Vomiting—Dexamethasone—ankylosing spondylitis	1.82e-05	0.00153	CcSEcCtD
Pemetrexed—Decreased appetite—Methotrexate—ankylosing spondylitis	1.81e-05	0.00152	CcSEcCtD
Pemetrexed—Rash—Betamethasone—ankylosing spondylitis	1.81e-05	0.00151	CcSEcCtD
Pemetrexed—Rash—Dexamethasone—ankylosing spondylitis	1.81e-05	0.00151	CcSEcCtD
Pemetrexed—Dermatitis—Dexamethasone—ankylosing spondylitis	1.8e-05	0.00151	CcSEcCtD
Pemetrexed—Dermatitis—Betamethasone—ankylosing spondylitis	1.8e-05	0.00151	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	1.8e-05	0.00151	CcSEcCtD
Pemetrexed—Fatigue—Methotrexate—ankylosing spondylitis	1.8e-05	0.00151	CcSEcCtD
Pemetrexed—Asthenia—Prednisone—ankylosing spondylitis	1.79e-05	0.0015	CcSEcCtD
Pemetrexed—Pain—Methotrexate—ankylosing spondylitis	1.78e-05	0.00149	CcSEcCtD
Pemetrexed—Pruritus—Prednisone—ankylosing spondylitis	1.77e-05	0.00148	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Prednisone—ankylosing spondylitis	1.74e-05	0.0186	CbGdCrCtD
Pemetrexed—Diarrhoea—Prednisone—ankylosing spondylitis	1.71e-05	0.00143	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	1.7e-05	0.00143	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Prednisolone—ankylosing spondylitis	1.7e-05	0.0182	CbGdCrCtD
Pemetrexed—Nausea—Dexamethasone—ankylosing spondylitis	1.7e-05	0.00143	CcSEcCtD
Pemetrexed—Nausea—Betamethasone—ankylosing spondylitis	1.7e-05	0.00143	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Methylprednisolone—ankylosing spondylitis	1.68e-05	0.0179	CbGdCrCtD
Pemetrexed—Urticaria—Methotrexate—ankylosing spondylitis	1.66e-05	0.00139	CcSEcCtD
Pemetrexed—Dizziness—Prednisone—ankylosing spondylitis	1.65e-05	0.00138	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Dexamethasone—ankylosing spondylitis	1.65e-05	0.0176	CbGdCrCtD
Pemetrexed—TYMS—Budesonide—Betamethasone—ankylosing spondylitis	1.65e-05	0.0176	CbGdCrCtD
Pemetrexed—Abdominal pain—Methotrexate—ankylosing spondylitis	1.65e-05	0.00138	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—ankylosing spondylitis	1.65e-05	0.00138	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Triamcinolone—ankylosing spondylitis	1.61e-05	0.0172	CbGdCrCtD
Pemetrexed—Vomiting—Prednisone—ankylosing spondylitis	1.59e-05	0.00133	CcSEcCtD
Pemetrexed—Rash—Prednisone—ankylosing spondylitis	1.57e-05	0.00132	CcSEcCtD
Pemetrexed—Dermatitis—Prednisone—ankylosing spondylitis	1.57e-05	0.00132	CcSEcCtD
Pemetrexed—Hypersensitivity—Methotrexate—ankylosing spondylitis	1.54e-05	0.00129	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Prednisone—ankylosing spondylitis	1.53e-05	0.0163	CbGdCrCtD
Pemetrexed—Asthenia—Methotrexate—ankylosing spondylitis	1.5e-05	0.00125	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Prednisolone—ankylosing spondylitis	1.49e-05	0.0159	CbGdCrCtD
Pemetrexed—Nausea—Prednisone—ankylosing spondylitis	1.48e-05	0.00124	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—ankylosing spondylitis	1.48e-05	0.00124	CcSEcCtD
Pemetrexed—TYMS—Danazol—Prednisone—ankylosing spondylitis	1.47e-05	0.0157	CbGdCrCtD
Pemetrexed—Diarrhoea—Methotrexate—ankylosing spondylitis	1.43e-05	0.00119	CcSEcCtD
Pemetrexed—Dizziness—Methotrexate—ankylosing spondylitis	1.38e-05	0.00115	CcSEcCtD
Pemetrexed—Vomiting—Methotrexate—ankylosing spondylitis	1.33e-05	0.00111	CcSEcCtD
Pemetrexed—Rash—Methotrexate—ankylosing spondylitis	1.31e-05	0.0011	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—ankylosing spondylitis	1.31e-05	0.0011	CcSEcCtD
Pemetrexed—Nausea—Methotrexate—ankylosing spondylitis	1.24e-05	0.00104	CcSEcCtD
